Congenital Heart Disease

Volume 13, Issue 3 pp. 347-348

EDITORIAL

What is our future?

Hugh D. Allen MD, 

Hugh D. Allen MD

Search for more papers by this author

Hugh D. Allen MD, 

Hugh D. Allen MD

Search for more papers by this author

First published: 07 June 2018

https://doi.org/10.1111/chd.12628

Citations: 1

No abstract is available for this article.

REFERENCES

• 1 Redington AN. Consolidate or constipate: What are we going to do with all our registries? Congenital Heart Disease. 2017; 12: 559–560.
  10.1111/chd.12527

  PubMed Web of Science® Google Scholar
• 2 Mendell JR, Rodino-Klapac LR, Sahenk Z, et al., and the Eteplirsen Study Group. Etiplirsen for the Treatment of Duchenne Muscular Dystrophy. Annals of Neurology. 2013; 74: 637–647.
  10.1002/ana.23982

  CAS PubMed Web of Science® Google Scholar
• 3 Ross RD, Srivastava S, Cabrera AG, et al. The United States pediatric cardiology 2015 workforce assessment: A survey of current training and employment patterns. A report of the American College of Cardiology, American Heart Association, American Academy of Pediatrics Section on Cardiology and Cardiac Surgery and Society for Pediatric Cardiology Training Program Directors. J Am Coll Cardiol. 2016 Nov 28 [Epub ahead of print].
  Google Scholar
• 4 Penny DJ. Speaking to children and their families about congenital heart disease: Ushering in a new era of healthcare literacy. Congenital Heart Disease. 2017; 12: 241.
  10.1111/chd.12474

  PubMed Web of Science® Google Scholar
• 5 Lock JE. Are the spin doctors winning? Congenital Heart Disease. 2017; 12: 697–698.
  10.1111/chd.12548

  PubMed Web of Science® Google Scholar

Citing Literature

Volume13, Issue3

May/June 2018

Pages 347-348

• References

• Related

• Information

Close Figure Viewer

Previous FigureNext Figure

Caption

Download PDF